168 related articles for article (PubMed ID: 9365633)
1. Mycophenolate mofetil rescue therapy in liver transplant recipients: an extended follow-up.
Gavlik A; Demirbas A; Tsaroucha A; Webb MG; Nery JR; Khan MF; Karatzas T; Khan RT; Zucker K; Viciana AL; Miller JA; Tzakis AG
Transplant Proc; 1997 Nov; 29(7):2971-2. PubMed ID: 9365633
[No Abstract] [Full Text] [Related]
2. Mycophenolate mofetil in combination with tacrolimus versus Neoral after liver transplantation.
Klupp J; Glanemann M; Bechstein WO; Platz KP; Langrehr JM; Keck H; Settmacher U; Radtke C; Neuhaus R; Neuhaus P
Transplant Proc; 1999; 31(1-2):1113-4. PubMed ID: 10083497
[No Abstract] [Full Text] [Related]
3. Mycophenolate mofetil rescue therapy in liver transplant recipients.
Gavlik A; Goldberg MG; Tsaroucha A; Webb MG; Khan RT; Weppler D; Nery JR; Khan MF; Zucker K; Viciana AL; Miller JA; Tzakis AG
Transplant Proc; 1997; 29(1-2):549-52. PubMed ID: 9123124
[No Abstract] [Full Text] [Related]
4. How to handle mycophenolate mofetil in combination with tacrolimus?
Braun F; Canelo R; Schütz E; Shipkora M; Lorf T; Hanack U; Niedmann D; Armstrong VW; Oellerich M; Ringe B
Transplant Proc; 1998 Dec; 30(8):4094-5. PubMed ID: 9865309
[No Abstract] [Full Text] [Related]
5. Replacement of corticosteroids by mycophenolate mofetil in liver graft recipients on initial tacrolimus immunosuppression.
Ringe B; Braun F; Wietzke P; Oellerich M; Ramadori G
Transplant Proc; 2000 Nov; 32(7):2543. PubMed ID: 11120285
[No Abstract] [Full Text] [Related]
6. FK 506 and mycofenolate mofetil rescue for acute steroid-resistant and chronic rejection after liver transplantation.
Platz KP; Mueller AR; Neuhaus R; Keck HH; Lobeck H; Neuhaus P
Transplant Proc; 1997 Nov; 29(7):2872-4. PubMed ID: 9365598
[No Abstract] [Full Text] [Related]
7. Steroid-free regimen with daclizumab, mycophenolate mofetil, and tacrolimus in liver transplant recipients.
Figueras J; Bernardos A; Prieto M; Gómez M; Rimola A; Ortiz de Urbina J; Cuervas-Mons V; de la Mata M; Dominguez-Granados R
Transplant Proc; 2002 Aug; 34(5):1511-3. PubMed ID: 12176461
[No Abstract] [Full Text] [Related]
8. A prospective study comparing safety and efficacy of mycophenolate mofetil versus azathioprine in primary liver transplant recipients.
Fischer L; Sterneck M; Gahlemann CG; Malago M; Rogiers X; Broelsch CE
Transplant Proc; 2000 Nov; 32(7):2125-7. PubMed ID: 11120098
[No Abstract] [Full Text] [Related]
9. Tacrolimus and mycophenolate mofetil in cadaveric renal transplant recipients. The European Multicentre Tacrolimus/MMF Study Group.
Forsythe J
Transplant Proc; 1999 Nov; 31(7A):69S-71S. PubMed ID: 10576049
[No Abstract] [Full Text] [Related]
10. Mycophenolate mofetil for treatment of chronic rejection in liver allograft under tacrolimus.
Daly I; Jain A; Reyes J; Fung J
Transplant Proc; 2002 Aug; 34(5):1503. PubMed ID: 12176458
[No Abstract] [Full Text] [Related]
11. Tolerability of mycophenolate mofetil in organ transplant recipients.
Schweizer RT; Meisterling LD
Transplant Proc; 2001 May; 33(3):2309. PubMed ID: 11377540
[No Abstract] [Full Text] [Related]
12. Simultaneous use of tacrolimus and mycophenolate mofetil in combined pancreas-kidney transplant recipients: a multi-center report. The FK/MMF Multi-Center Study Group.
Stratta RJ
Transplant Proc; 1997; 29(1-2):654-5. PubMed ID: 9123463
[No Abstract] [Full Text] [Related]
13. Tacrolimus and mycophenolate mofetil in clinical liver transplantation: experience with a steroid-sparing concept.
Ringe B; Braun F; Lorf T; Canelo R; Schütz E; Sattler B; Ramadori G
Transplant Proc; 1998 Jun; 30(4):1415-6. PubMed ID: 9636573
[No Abstract] [Full Text] [Related]
14. Indications for mycofenolate mofetil therapy after liver transplantation.
Platz KP; Mueller AR; Neuhaus P
Transplant Proc; 1997 Nov; 29(7):2880-1. PubMed ID: 9365601
[No Abstract] [Full Text] [Related]
15. New immunosuppressive agents in clinical use: mycophenolate mofetil and tacrolimus.
Hunt SA
Cardiol Rev; 2000; 8(3):180-4. PubMed ID: 11174892
[TBL] [Abstract][Full Text] [Related]
16. Conversion from calcineurin inhibitors to mycophenolate mofetil in liver transplant recipients with diabetes mellitus.
Herrero JI; Quiroga J; Sangro B; Pardo F; Rotellar F; Cienfuegos JA; Prieto J
Transplant Proc; 2003 Aug; 35(5):1877-9. PubMed ID: 12962832
[TBL] [Abstract][Full Text] [Related]
17. Co-administration of tacrolimus and mycophenolate mofetil in cadaveric renal transplant recipients.
Vanrenterghem Y; Squifflet JP; Forsythe J; Heeman U; Bäckman L; Taube D; Morales JM; Ekberg H; van Hooff J; Zanker B; Dietl KH; Talbot D; Hauser I; Tydén G; Claesson K; Mühlbacher F
Transplant Proc; 1998 Jun; 30(4):1290-1. PubMed ID: 9636523
[No Abstract] [Full Text] [Related]
18. Mycophenolate mofetil rescue therapy in patients with chronic hepatic allograft rejection.
Kato T; Ruiz P; DeFaria W; Weppler D; Khan F; Pinna A; Nery J; Tzakis A
Transplant Proc; 1999; 31(1-2):396. PubMed ID: 10083158
[No Abstract] [Full Text] [Related]
19. Use of mycophenolate mofetil in liver transplant recipients experiencing renal dysfunction on cyclosporine or tacrolimus-randomized, prospective, multicenter study results.
Hodge EE; Reich DJ; Clavien PA; Kim-Schluger L
Transplant Proc; 2002 Aug; 34(5):1546-7. PubMed ID: 12176477
[No Abstract] [Full Text] [Related]
20. A prospective, randomized trial of tacrolimus/prednisone vs tacrolimus/prednisone/mycophenolate mofetil in renal transplantation: 1-year actuarial follow-up.
Shapiro R; Jordan ML; Scantlebury VP; Vivas C; Marsh JW; McCauley J; Johnston J; Randhawa P; Irish W; Gritsch HA; Naraghi R; Hakala TR; Fung JJ; Starzl TE
Transplant Proc; 1999; 31(1-2):1134. PubMed ID: 10083507
[No Abstract] [Full Text] [Related]
[Next] [New Search]
